Ain Holdings Inc. · TSE:9627
Ain — Q3 FY4/23 Earnings Presentation
13 slides from Ain's earnings presentation, Mar 3, 2023
Slide 1: FY4/23 3Q IR Presentation
FY4/23 3Q IR PRESENTATION March 2023
Slide 2: Results Overview
Results Overview © 2023 AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales increased 12.5% YoY and declined 1.2% against the plan due to new store openings and contribution of existing stores, despite the impact of the COVID-19. Ordinary profit increased 14.5% YoY and declined 14.1% against the plan due to increase of sales. FY4/22 3Q FY4/23 3Q F
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 12.7% YoY and declined 1.2% against the plan due to new store openings including M&A and contribution of stores opened previous year. Segment profit increased 1.3% YoY and declined 14.4% against the plan. FY4/22 3Q FY4/23 3Q FY4/23 3Q Y
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Net sales up 23.2% YoY and 0.4% against the plan due to the recovery of existing stores and contribution of stores opened in previous year despite the impact of the COVID-19. Segment profit was ¥737 million, ¥672 million above the plan. FY4/22 3Q FY4/2
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥36,041 million and shareholdersʼ equity ratio became 53.9%. We are maintaining a sound financial structure even under the ongoing COVID-19 situation. End-FY4/22 (¥ million) End-FY4/23 3Q (¥ million) Assets Liabilities Assets Liabilities Current assets Current Curren
Slide 7: Assets
Assets The balance of total assets increased ¥17,101 million from the end of the previous fiscal year due to decrease of cash on hand and in banks and increase of inventories and goodwill. (¥ million) End-FY4/22 3Q End-FY4/22 End-FY4/23 3Q Change Cash on hand and in banks 55,641 59,729 46,193 (13,53
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets Accounts payable increased ¥10,216 million due to new store openings including M&A. Short- term and long-term debt increased ¥1,394 million. (¥ million) End-FY4/22 3Q End-FY4/22 End-FY4/23 3Q Change Accounts payable 52,276 50,756 60,972 +10,216 Short-term debt 2,746 2,643
Slide 9: Revised plan
Revised plan © 2023 AIN HOLDINGS INC. All Rights Reserved. 8
Slide 10: FY4/23 Revised Plan (Consolidated)
FY4/23 Revised Plan (Consolidated) Although sales and profit in the cosmetic and drug store business achieved plan, the recovery in the number of prescriptions in the dispensing pharmacy business is slower than initially expected. The group revised the plan, net sales increase 13.2% YoY and ordinary
Slide 11: FY4/23 Revised Plan (Dispensing Pharmacy Business)
FY4/23 Revised Plan (Dispensing Pharmacy Business ) FY4/22 FY4/23 FY4/23 YoY Vs initial plan （¥ million） results initial plan revised plan Change(%) change (%) Net sales 283,111 326,000 321,560 +13.6 (1.4) Gross profit 38,194 44,920 41,350 +8.3 (7.9) % of net sales 13.5 13.8 12.9 SG&A expenses 13,87
Slide 12: FY4/23 Revised Plan (Cosmetic and Drug Store Business)
FY4/23 Revised Plan (Cosmetic and Drug Store Business ) FY4/22 FY4/23 FY4/23 YoY Vs initial plan （¥ million） results initial plan revised plan Change(%) change (%) Net sales 20,558 24,727 24,920 +21.2 +0.8 Gross profit 7,030 9,350 9,410 +33.9 +0.6 % of net sales 34.2 37.8 37.8 SG&A expenses 8,858 9,
Slide 13: AIN HOLDINGS INC. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document ha